TrialJAMA oncology2020

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.

David A Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.